Prevalence and clinical challenges among adults with primary immunodeficiency and recombination-activating gene deficiency

Journal of Allergy and Clinical Immunology

Volumn 141, Issue 6, 2018, Pages 2303-2306

  Lawless, Dylan ^a   Geier, Christoph B ^b   Farmer, Jocelyn R ^c   Lango Allen, Hana ^d,e   Thwaites, Daniel ^a   Atschekzei, Faranaz ^f   Brown, Matthew ^d,e   Buchbinder, David ^g   Burns, Siobhan O ^h,i   Butte, Manish J ^j   Csomos, Krisztian ^k   Deevi, Sri V V ^d,e   Egner, William ^l   Ehl, Stephan ^m,n   Eibl, Martha M ^b,o   Fadugba, Olajumoke ^p   Foldvari, Zsofia ^q   Green, Deanna M ^r   Henrickson, Sarah E ^s   Holland, Steven M ^t   John, Tami ^g   Klemann, Christian ^f   Kuijpers, Taco W ^u,v   Moreira, Fernando ^h   Piller, Alexander ^b   Rayner Matthews, Paula ^d,e   Romberg, Neil D ^w   Sargur, Ravishankar ^l   Schmidt, Reinhold E ^f   Schröder, Claudia ^f   Schuetz, Catharina ^x   Sharapova, Svetlana O ^y   Smith, Ken G C ^e   Sogkas, Georgios ^f   Speckmann, Carsten ^d,n   Stirrups, Kathleen ^d,e   Thrasher, Adrian J ^z   Wolf, Hermann M ^b,aa   Notarangelo, Luigi D ^t   Anwar, Rashida ^a   Boyes, Joan ^a   Ujhazi, Boglarka ^k   Thaventhiran, James ^e   Walter, Jolan E ^c,k   Savic, Sinisa ^ab,ac   more..

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b Immunology Outpatient Clinic   (Austria)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f HANNOVER MEDICAL SCHOOL   (Germany)

^g CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^h ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIVERSITY OF SOUTH FLORIDA   (United States)

^l SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^m UNIVERSITY OF FREIBURG   (Germany)

ⁿ UNIVERSITY OF FREIBURG   (Germany)

^o Biomech Forschungs GmbH   (Austria)

^p UNIVERSITY OF PENNSYLVANIA   (United States)

^q OSLO UNIVERSITY HOSPITAL   (Norway)

^r JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

^s UNIVERSITY OF PENNSYLVANIA   (United States)

^t NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^u EMMA CHILDREN S HOSPITAL   (Netherlands)

^v UNIVERSITY OF AMSTERDAM   (Netherlands)

^w YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^x UNIVERSITY HOSPITAL ULM   (Germany)

^y Belarusian Research Center for Pediatric Oncology Hematology and Immunology   (Belarus)

^z GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^aa MEDICAL UNIVERSITY OF VIENNA   (Austria)

^ab ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^ac Chapel Allerton Hospital   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RAG1 PROTEIN; RAG2 PROTEIN; T LYMPHOCYTE RECEPTOR; DNA BINDING PROTEIN; HOMEODOMAIN PROTEIN; NUCLEAR PROTEIN; RAG-1 PROTEIN; RAG2 PROTEIN, HUMAN;

ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FORCED VITAL CAPACITY; GENETIC ANALYSIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE DEFICIENCY; LUNG FUNCTION; NEUTROPENIA; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECOMBINATION ACTIVATING GENE DEFICIENCY; ADULT; DEFICIENCY; GENETICS; IMMUNOLOGY; PATHOPHYSIOLOGY;

ADULT; DNA-BINDING PROTEINS; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; NUCLEAR PROTEINS; PREVALENCE;

EID: 85044596801     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2018.02.007     Document Type: Article

References (10)

1. Kumanovics, A., Lee, Y.N., Close, D.W., Coonrod, E.M., Ujhazi, B., Chen, K., et al. Estimated disease incidence of RAG1/2 mutations: a case report and querying the Exome Aggregation Consortium. J Allergy Clin Immunol 139 (2017), 690–692.e3.
2. Kwan, A., Abraham, R.S., Currier, R., Brower, A., Andruszewski, K., Abbott, J.K., et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA 312 (2014), 729–738.
3. Schwarz, K., Gauss, G.H., Ludwig, L., Pannicke, U., Li, Z., Lindner, D., et al. RAG mutations in human B cell-negative SCID. Science 274 (1996), 97–99.
4. Felgentreff, K., Perez-Becker, R., Speckmann, C., Schwarz, K., Kalwak, K., Markelj, G., et al. Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency. Clin Immunol 141 (2011), 73–82.
5. Walter, J.E., Rosen, L.B., Csomos, K., Rosenberg, J.M., Mathew, D., Keszei, M., et al. Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency. J Clin Invest 125 (2015), 4135–4148.
6. Buchbinder, D., Baker, R., Lee, Y.N., Ravell, J., Zhang, Y., McElwee, J., et al. Identification of patients with RAG mutations previously diagnosed with common variable immunodeficiency disorders. J Clin Immunol 35 (2015), 119–124.
7. Geier, C.B., Piller, A., Linder, A., Sauerwein, K.M., Eibl, M.M., Wolf, H.M., Leaky RAG deficiency in adult patients with impaired antibody production against bacterial polysaccharide antigens. PLoS One, 10, 2015, e0133220.
8. Tuijnenburg, P., Lango Allen, H., Burns, S.O., Greene, D., Jansen, M.H., Staples, E., et al. Loss of function NFKB1 variants are the most common monogenic cause of CVID in Europeans. J Allergy Clin Immunol, 2018 Feb 22, 10.1016/j.jaci.2018.01.039 [Epub ahead of print].
9. Lee, Y.N., Frugoni, F., Dobbs, K., Walter, J.E., Giliani, S., Gennery, A.R., et al. A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency. J Allergy Clin Immunol 133 (2014), 1099–1108.
10. Speckmann, C., Doerken, S., Aiuti, A., Albert, M.H., Al-Herz, W., Allende, L.M., et al. A prospective study on the natural history of patients with profound combined immunodeficiency: an interim analysis. J Allergy Clin Immunol 139 (2017), 1302–1310.e4.